Home ID">Hair Loss Treatments ID">Off-Label Treatments Tacrolimus (Fujimycin, FK506) Tacrolimus (Fujimycin, FK506) Hair Loss Treatment Type: Immunosuppressive Availability: Prescription Notes: FK506 is an immunosuppressant, like cyclosporin, primarily used to prevent organ rejection. Like Cyclosporin, it also has hair growth effects; however, unlike cyclosporin, it is more effective topically for hair growth than orally, making it a better choice than cyclosporin. Unfortunately, like cyclosporin, it also has the potential for serve side effects and is not to be used lightly. Claimed Results: None. Observed Results: Unknown. Clinical Results: Some clinical studies showing it works for hair growth. Testing: Some (FDA Approved). Safety/Side Effects: Toxicity and possible neural damage when taken orally. Unknown topical effects. Gender: Either. Typical Cost: Unknown. Related Pages Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506 Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus) Name (required) Mail (will not be published) (required) Website Leave a Comment Cancel reply You must be logged in to post a comment.